UCapital NewsBusiness Super App · news connected to data, companies, people and deals
IT
VoicesWire
LIVE
BREAKING LIVE

The news moving markets, right now

From international newswires in real time. For every story the News Impact AI agent estimates the market impact and flags the assets to watch, with the story’s impact on each: positive, negative or neutral.

STORIES TODAY
594
via finance.yahoo.comBusiness & Companies

What Does Eli Lilly (LLY) Gain From This $870 Million Drug Discovery Deal?

FROM THE WIRE · FINANCE.YAHOO.COM

Eli Lilly (NYSE:LLY) expanded its drug discovery alliance with Gate Bioscience in a potential US$870m multi-year deal. The broadened collaboration targets difficult-to-drug proteins using Gate Bioscience's discovery platform across high unmet-need disease areas. Lilly obtained…

Read at the source ↗
MARKET IMPACTNEUTRAL✦ News Impact agent estimateTone: expected bullishEli Lilly expands drug discovery alliance with Gate Bioscience in $870 million multi-year deal targeting hard-to-drug proteins.AI-generated summary
✦ IN BRIEF · AIAI-generated summary
  1. 01Eli Lilly expanded drug discovery alliance with Gate Bioscience in potential $870 million multi-year deal.
  2. 02Broadened collaboration targets difficult-to-drug proteins using Gate Bioscience's discovery platform.
  3. 03Lilly obtained global development and commercialization rights for therapies emerging from the partnership.
NEWS IMPACT AND MARKET REACTIONChange from the reference price
Eli Lilly and CompanyLLYStock1,185.47 USD-0.96%today +2.42%Positive
Impact and summary are estimates by the News Impact AI agent, not financial advice.Open in Markets

ALL BREAKING TODAY

Breaking live stories come from third-party newswires via feed; headline and summary belong to the stated source. Impact analysis: UCapital AI · News Impact.

UCapital News is the news section of UCapital24 S.p.A. All content is for information purposes only and does not constitute financial advice, a recommendation or a solicitation to invest. Even where terms such as “buy”, “sell”, “bullish” or “bearish”, or asset impact signals, appear, they only indicate the possible effect of a news item on the markets and are not an invitation to buy or sell financial instruments. News is analysed with UCapital AI and may also be published via API feeds from third-party providers, to give our users a continuous flow of news. UCapital24 S.p.A. accepts no liability of any kind for decisions made on the basis of this content. Wire releases are published by companies and are not verified by the newsroom.

AI use policy. UCapital AI supports the newsroom with news analysis, summaries, market reactions, translations and the generation of cards and charts. AI-generated or AI-assisted content is labelled in the byline (AI Desk or joint byline) and is reviewed by editors before publication. News received via API feeds from third-party providers is attributed to the original source. AI can make mistakes: report any inaccuracies to the newsroom. Users’ personal data is not used to train the models.